Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Drug Therapy For Torsade de Pointes
SHMUEL BANAI
*
, DAN TZIVONI
*
Corresponding author for this work
Bikur Cholim Hospital
Research output
:
Contribution to journal
›
Review article
›
peer-review
84
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Drug Therapy For Torsade de Pointes'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Drug Therapy
100%
Torsades Des Pointes
100%
Arrhythmia
30%
Heart Rate
20%
Ventricular Tachycardia
20%
QT Interval
20%
Atropine
10%
Morphological Characteristics
10%
Clinical Significance
10%
Treatment Choice
10%
Heart Block
10%
Isoproterenol
10%
Predisposing Factors
10%
Hypokalemia
10%
Sinus Bradycardia
10%
Quinidine
10%
Hypomagnesemia
10%
Disopyramide
10%
Intravenous Magnesium Sulfate
10%
Antiarrhythmic Agents
10%
Cardiac Pacing
10%
Antiarrhythmic Therapy
10%
Electrolyte Imbalance
10%
QT-prolonging Drugs
10%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacotherapy
100%
Torsade Des Pointes
100%
Heart Arrhythmia
30%
Heart Ventricle Tachycardia
20%
Antiarrhythmic Drug
20%
Recurrent Disease
10%
Heart Block
10%
Disease Predisposition
10%
Hypokalemia
10%
Sinus Bradycardia
10%
Antiarrhythmic Agent
10%
Quinidine
10%
Isoprenaline
10%
Magnesium Sulfate
10%
Electrolyte Disturbance
10%
Hypomagnesemia
10%
Disopyramide
10%